应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06833 兴科蓉医药
已收盘 04-19 16:08:35
0.245
-0.005
-2.00%
最高
0.245
最低
0.230
成交量
2.00万
今开
0.230
昨收
0.250
日振幅
6.00%
总市值
4.98亿
流通市值
4.98亿
总股本
20.33亿
成交额
4,660
换手率
0.00%
流通股本
20.33亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
兴科蓉医药(06833)股价下跌8%,现价港币$0.23
阿斯达克财经 · 11:53
兴科蓉医药(06833)股价下跌8%,现价港币$0.23
兴科蓉医药(6833.HK):营收同比增长11.8%,蓄势待发
格隆汇 · 04-02
兴科蓉医药(6833.HK):营收同比增长11.8%,蓄势待发
兴科蓉医药公布2023年度业绩:持续深耕血制品赛道布局,医美产业成发展亮点
财华社 · 03-28
兴科蓉医药公布2023年度业绩:持续深耕血制品赛道布局,医美产业成发展亮点
兴科蓉医药(06833)公布2023年度业绩 核心产品成绩优异 双赛道布局持续深化推进
智通财经 · 03-27
兴科蓉医药(06833)公布2023年度业绩 核心产品成绩优异 双赛道布局持续深化推进
《公司业绩》兴科蓉医药(06833.HK)全年纯利4,235.2万人币跌39% 派末期息0.39港仙
阿斯达克财经 · 03-27
《公司业绩》兴科蓉医药(06833.HK)全年纯利4,235.2万人币跌39% 派末期息0.39港仙
兴科蓉医药(06833)发布年度业绩,股东应占溢利4235.2万元 同比减少39.03% 末期息每股0.39港仙
智通财经 · 03-26
兴科蓉医药(06833)发布年度业绩,股东应占溢利4235.2万元 同比减少39.03% 末期息每股0.39港仙
兴科蓉医药(06833)将于6月4日派发末期股息每股0.0039港元
智通财经网 · 03-26
兴科蓉医药(06833)将于6月4日派发末期股息每股0.0039港元
兴科蓉医药(06833):黄智健获委任为执行董事
智通财经 · 03-26
兴科蓉医药(06833):黄智健获委任为执行董事
兴科蓉医药(06833)股价显著上升10.204%,现价港币$0.27
阿斯达克财经 · 03-25
兴科蓉医药(06833)股价显著上升10.204%,现价港币$0.27
兴科蓉医药(06833)股价下跌7.308%,现价港币$0.241
阿斯达克财经 · 03-22
兴科蓉医药(06833)股价下跌7.308%,现价港币$0.241
兴科蓉医药(06833.HK)3月26日举行董事会会议考虑及批准年度业绩
格隆汇资讯 · 03-14
兴科蓉医药(06833.HK)3月26日举行董事会会议考虑及批准年度业绩
《盈警响号》兴科蓉医药(06833.HK)开支增加 料全年纯利跌39.6%
阿斯达克财经 · 03-14
《盈警响号》兴科蓉医药(06833.HK)开支增加 料全年纯利跌39.6%
兴科蓉医药(06833)发盈警 预期2023年度股东应占纯利约4200万元 同比减少约39.6%
智通财经 · 03-13
兴科蓉医药(06833)发盈警 预期2023年度股东应占纯利约4200万元 同比减少约39.6%
兴科蓉医药(06833)股价大幅下跌18.077%,现价港币$0.213
阿斯达克财经 · 03-06
兴科蓉医药(06833)股价大幅下跌18.077%,现价港币$0.213
兴科蓉医药(06833)股价下跌7.407%,现价港币$0.25
阿斯达克财经 · 02-26
兴科蓉医药(06833)股价下跌7.407%,现价港币$0.25
兴科蓉医药(06833)股价大幅上升17.257%,现价港币$0.265
阿斯达克财经 · 02-21
兴科蓉医药(06833)股价大幅上升17.257%,现价港币$0.265
兴科蓉医药(06833)股价下跌5.769%,现价港币$0.245
阿斯达克财经 · 02-16
兴科蓉医药(06833)股价下跌5.769%,现价港币$0.245
兴科蓉医药(06833)股价显著上升11.321%,现价港币$0.295
阿斯达克财经 · 02-01
兴科蓉医药(06833)股价显著上升11.321%,现价港币$0.295
兴科蓉医药(6833.HK)荣获“金格奖——年度卓越IR团队”奖
格隆汇资讯 · 2023-12-21
兴科蓉医药(6833.HK)荣获“金格奖——年度卓越IR团队”奖
兴科蓉医药11月13日主力资金流出12万元 连续3日减仓
自选股智能写手 · 2023-11-13
兴科蓉医药11月13日主力资金流出12万元 连续3日减仓
加载更多
公司概况
公司名称:
兴科蓉医药
所属市场:
SEHK
上市日期:
--
主营业务:
兴科蓉医药控股有限公司主要在中华人民共和国(中国)制药行业提供营销、推广和渠道管理(MPCM)服务。该公司向在中国没有独立营销和推广能力的中小型海外制药厂商提供综合的MPCM服务。其主要产品是人血清蛋白注射液。该产品是由Octapharma制造的人血清蛋白,用于治疗血容量不足和低血容量性休克、异常高的颅内压、水肿和腹水,以及预防和治疗低白蛋白血症和新生儿高胆红素血症。此外,其产品还包括安可欣、麦道必、爱赛福、泰特和滔罗特等。
发行价格:
--
{"stockData":{"symbol":"06833","market":"HK","secType":"STK","nameCN":"兴科蓉医药","latestPrice":0.245,"timestamp":1713514115035,"preClose":0.25,"halted":0,"volume":20000,"delay":0,"floatShares":2032890585,"shares":2032890585,"eps":0.022511506,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.005,"latestTime":"04-19 16:08:35","open":0.23,"high":0.245,"low":0.23,"amount":4660,"amplitude":0.06,"askPrice":0.25,"askSize":64000,"bidPrice":0.24,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":0.02251150671282879,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1457539200000,"adjPreClose":0.25,"dividendRate":0.015608,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.423729,"lotSize":4000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06833","defaultTab":"news","newsList":[{"id":"2428099625","title":"兴科蓉医药(06833)股价下跌8%,现价港币$0.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2428099625","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428099625?lang=zh_cn&edition=full","pubTime":"2024-04-19 11:53","pubTimestamp":1713498780,"startTime":"0","endTime":"0","summary":"[下跌股]兴科蓉医药(06833) 股价在上午11:53比前收市价下跌8%,现股价为港币$0.23。至目前为止,今日最高价为$0.23,而最低价为$0.23。总成交量为1.6万股,总成交金额为港币$3680。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404193064/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2424610700","title":"兴科蓉医药(6833.HK):营收同比增长11.8%,蓄势待发","url":"https://stock-news.laohu8.com/highlight/detail?id=2424610700","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2424610700?lang=zh_cn&edition=full","pubTime":"2024-04-02 08:33","pubTimestamp":1712018022,"startTime":"0","endTime":"0","summary":"从兴科蓉医药的当前营收表现和未来布局来看,公司管理层具有前瞻性的战略眼光和敏锐的市场洞察力。","market":"hk","thumbnail":"https://img2.gelonghui.com/e55e7-55c02804-ea5f-4487-a5bc-8ee908937591.jpg?guru_height=1080&guru_width=1920","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/e55e7-55c02804-ea5f-4487-a5bc-8ee908937591.jpg?guru_height=1080&guru_width=1920"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/715103","is_publish_highlight":false,"gpt_icon":0},{"id":"2422158885","title":"兴科蓉医药公布2023年度业绩:持续深耕血制品赛道布局,医美产业成发展亮点","url":"https://stock-news.laohu8.com/highlight/detail?id=2422158885","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2422158885?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:32","pubTimestamp":1711611147,"startTime":"0","endTime":"0","summary":"作为疫后恢复的第一年,2023年是医药赛道很多企业成长性和专业性面对重重考验的一年。创新药估值回落,化药受集采影响销售额缩减,验证医药企业增长潜力和韧性发展的时刻到来。不过,从近期披露的业绩报告来看,仍然有不少公司通过在细分赛道持续深耕,交出了一份正向增长的成绩单。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202403_1/d7bc5d3d-bc67-4ac5-a0e3-e31c872853d6.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202403_1/d7bc5d3d-bc67-4ac5-a0e3-e31c872853d6.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/66051d0b53243c3513e4bd01","is_publish_highlight":false,"gpt_icon":0},{"id":"2422023356","title":"兴科蓉医药(06833)公布2023年度业绩 核心产品成绩优异 双赛道布局持续深化推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2422023356","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422023356?lang=zh_cn&edition=full","pubTime":"2024-03-27 09:57","pubTimestamp":1711504677,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月26日晚,兴科蓉医药公布2023全年业绩,收益增长11.8%至人民币2,540.1百万元,其中人血白蛋白注射液销售收益增长约人民币249.8百万元,医美业务收益增加人民币13.7百万元。兴科蓉医药近期对既有的销售伙伴网络进行了细致的优化。此外,兴科蓉医药的正在进一步加强内部营销团队在产品市场推广活动中的主动作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1093112.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422085276","title":"《公司业绩》兴科蓉医药(06833.HK)全年纯利4,235.2万人币跌39% 派末期息0.39港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2422085276","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422085276?lang=zh_cn&edition=full","pubTime":"2024-03-27 08:10","pubTimestamp":1711498200,"startTime":"0","endTime":"0","summary":"兴科蓉医药(06833.HK) 公布截至去年12月底止全年业绩,营业额25.4亿元人民币(下同),按年升11.8%。纯利4,235.2万元,按年跌39%;每股盈利2.1分。派末期息0.39港仙,上年同期派0.98港仙。(ek/cy)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息:港元 0.00982022/09/01中期业绩无派息 2022/03/31末期业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230801172145032_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230801172145032_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1337387/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422617283","title":"兴科蓉医药(06833)发布年度业绩,股东应占溢利4235.2万元 同比减少39.03% 末期息每股0.39港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2422617283","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422617283?lang=zh_cn&edition=full","pubTime":"2024-03-26 23:05","pubTimestamp":1711465518,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药 发布截至2023年12月31日止年度业绩,该集团取得收益人民币25.4亿元,同比增加11.82%;公司拥有人应占溢利4235.2万元,同比减少39.03%;每股盈利0.021元,拟派发末期股息每股0.39港仙。报告期内,集团毛利增加1740万元至3.23亿元,毛利率则由2022年的13.5%下降至报告期内的12.7%。报告期内,集团纯利减少39.0%至4240万元,主要是由于集团扩大医美药物研究及制造分部以及医美服务分部的业务营运导致行政开支增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092947.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422761774","title":"兴科蓉医药(06833)将于6月4日派发末期股息每股0.0039港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422761774","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2422761774?lang=zh_cn&edition=full","pubTime":"2024-03-26 23:04","pubTimestamp":1711465463,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药(06833)发布公告,该公司将于2024年6月4日派发2023年度末期股息每股0.0039港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092944.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422614029","title":"兴科蓉医药(06833):黄智健获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2422614029","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422614029?lang=zh_cn&edition=full","pubTime":"2024-03-26 22:40","pubTimestamp":1711464058,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药(06833)发布公告,李健威已辞任公司联席公司秘书及香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表,自2024年3月26日起生效。于李先生辞任后,另一名联席公司秘书彭云璐将继续担任公司唯一公司秘书。彭女士已获承认为香港公司治理公会会员,因此符合根据上市规则第3.28及8.17条规定的公司秘书资格。彭女士亦已获委任为授权代表以接替李先生,自2024年3月26日起生效。根据公司组织章程大纲及细则所载第16.2条,黄智健获委任为公司执行董事,自2024年3月26日起生效,直至其获委任后公司下一届股东周年大会为止,届时将合资格于会上膺选连任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1092893.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422840532","title":"兴科蓉医药(06833)股价显著上升10.204%,现价港币$0.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2422840532","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422840532?lang=zh_cn&edition=full","pubTime":"2024-03-25 10:45","pubTimestamp":1711334700,"startTime":"0","endTime":"0","summary":"[上升股]兴科蓉医药(06833) 股价在上午10:45比前收市价显著上升10.204%,现股价为港币$0.27。至目前为止,今日最高价为$0.27,而最低价为$0.27。总成交量为4.8万股,总成交金额为港币$1.296万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403251103/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2421874688","title":"兴科蓉医药(06833)股价下跌7.308%,现价港币$0.241","url":"https://stock-news.laohu8.com/highlight/detail?id=2421874688","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2421874688?lang=zh_cn&edition=full","pubTime":"2024-03-22 10:15","pubTimestamp":1711073700,"startTime":"0","endTime":"0","summary":"[下跌股]兴科蓉医药(06833) 股价在上午10:15比前收市价下跌7.308%,现股价为港币$0.241。至目前为止,今日最高价为$0.285,而最低价为$0.241。总成交量为17.2万股,总成交金额为港币$4.636万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403221913/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2419089673","title":"兴科蓉医药(06833.HK)3月26日举行董事会会议考虑及批准年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2419089673","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2419089673?lang=zh_cn&edition=full","pubTime":"2024-03-14 17:51","pubTimestamp":1710409875,"startTime":"0","endTime":"0","summary":"格隆汇3月14日丨兴科蓉医药(06833.HK)宣布,公司将于2024年3月26日(星期二)举行董事会会议,藉以(其中包括)考虑及批准公司及其附属公司截至2023年12月31日止年度的业绩及其刊发,并考虑建议派发末期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314175304878112b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314175304878112b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419632107","title":"《盈警响号》兴科蓉医药(06833.HK)开支增加 料全年纯利跌39.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419632107","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419632107?lang=zh_cn&edition=full","pubTime":"2024-03-14 00:34","pubTimestamp":1710347640,"startTime":"0","endTime":"0","summary":"兴科蓉医药(06833.HK) 发盈警,预计2023年度纯利约4,200万人民币,较上年度减少2,750万人民币或39.6%。主要因集团扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/08/30中期业绩无派息2023/03/29末期业绩普通股息:港元 0.00982022/09/01中期业绩无派息 2022/03/31末期业绩无派息 AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20230801172145032_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20230801172145032_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333201/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2419754509","title":"兴科蓉医药(06833)发盈警 预期2023年度股东应占纯利约4200万元 同比减少约39.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419754509","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2419754509?lang=zh_cn&edition=full","pubTime":"2024-03-13 18:33","pubTimestamp":1710326027,"startTime":"0","endTime":"0","summary":"智通财经APP讯,兴科蓉医药(06833)发布公告,集团预期于截至2023年12月31日止年度(本年度)取得的公司权益持有人应占纯利约为人民币4200万元,较截至2022年12月31日止年度公司权益持有人应占纯利约人民币6950万元减少约人民币2750万元或约39.6%。公告称,纯利减少主要是由于集团于本年度扩大医美药物研究及制造分部以及医美分部的业务营运导致行政开支增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1085999.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417286033","title":"兴科蓉医药(06833)股价大幅下跌18.077%,现价港币$0.213","url":"https://stock-news.laohu8.com/highlight/detail?id=2417286033","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2417286033?lang=zh_cn&edition=full","pubTime":"2024-03-06 11:32","pubTimestamp":1709695920,"startTime":"0","endTime":"0","summary":"[下跌股]兴科蓉医药(06833) 股价在上午11:32比前收市价大幅下跌18.077%,现股价为港币$0.213。至目前为止,今日最高价为$0.226,而最低价为$0.213。总成交量为4.4万股,总成交金额为港币$9856。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403061415/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2414007484","title":"兴科蓉医药(06833)股价下跌7.407%,现价港币$0.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2414007484","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2414007484?lang=zh_cn&edition=full","pubTime":"2024-02-26 15:35","pubTimestamp":1708932900,"startTime":"0","endTime":"0","summary":"[下跌股]兴科蓉医药(06833) 股价在下午03:35比前收市价下跌7.407%,现股价为港币$0.25。至目前为止,今日最高价为$0.25,而最低价为$0.25。总成交量为6万股,总成交金额为港币$1.5万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2402261131/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2413491625","title":"兴科蓉医药(06833)股价大幅上升17.257%,现价港币$0.265","url":"https://stock-news.laohu8.com/highlight/detail?id=2413491625","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2413491625?lang=zh_cn&edition=full","pubTime":"2024-02-21 14:28","pubTimestamp":1708496880,"startTime":"0","endTime":"0","summary":"[上升股]兴科蓉医药(06833) 股价在下午02:28比前收市价大幅上升17.257%,现股价为港币$0.265。至目前为止,今日最高价为$0.265,而最低价为$0.265。总成交量为4000股,总成交金额为港币$1060。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2402217400/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2411633099","title":"兴科蓉医药(06833)股价下跌5.769%,现价港币$0.245","url":"https://stock-news.laohu8.com/highlight/detail?id=2411633099","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2411633099?lang=zh_cn&edition=full","pubTime":"2024-02-16 14:59","pubTimestamp":1708066740,"startTime":"0","endTime":"0","summary":"[下跌股]兴科蓉医药(06833) 股价在下午02:59比前收市价下跌5.769%,现股价为港币$0.245。至目前为止,今日最高价为$0.245,而最低价为$0.245。总成交量为2万股,总成交金额为港币$4900。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133700459_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2402162626/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2408579494","title":"兴科蓉医药(06833)股价显著上升11.321%,现价港币$0.295","url":"https://stock-news.laohu8.com/highlight/detail?id=2408579494","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2408579494?lang=zh_cn&edition=full","pubTime":"2024-02-01 15:05","pubTimestamp":1706771100,"startTime":"0","endTime":"0","summary":"[上升股]兴科蓉医药(06833) 股价在下午03:05比前收市价显著上升11.321%,现股价为港币$0.295。至目前为止,今日最高价为$0.295,而最低价为$0.295。总成交量为4000股,总成交金额为港币$1180。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2402013795/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2393086311","title":"兴科蓉医药(6833.HK)荣获“金格奖——年度卓越IR团队”奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2393086311","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2393086311?lang=zh_cn&edition=full","pubTime":"2023-12-21 19:07","pubTimestamp":1703156822,"startTime":"0","endTime":"0","summary":"12月20日—22日,格隆汇第八届全球投资嘉年华在深圳召开。在今日的格隆汇“金格奖”年度卓越公司评选中,兴科蓉医药(6833.HK)荣获“年度卓越IR团队”奖项。“年度卓越IR团队”奖旨在表彰优秀的上市公司IR团队为推动行业变革与发展作出的卓越贡献。在市场日渐成熟、监管趋于严格的今天,投关工作也向着“数字化”“精细化”“系统化”等方向发展。奖项评选着重关注IR团队与投资者之间的交流渠道建设、沟通联系,引领市场以长远的目光考量企业的综合表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231221192602876085de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231221192602876085de&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2383970727","title":"兴科蓉医药11月13日主力资金流出12万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2383970727","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2383970727?lang=zh_cn&edition=full","pubTime":"2023-11-13 16:15","pubTimestamp":1699863348,"startTime":"0","endTime":"0","summary":"11月13日, 兴科蓉医药股价跌3.28%,报收0.29元,成交金额19万元,换手率0.03%,振幅9.84%,量比1.33。兴科蓉医药今日主力资金净流出12万元,连续3日净流出,上一交易日主力净流出0万元。该股近5个交易日上涨18.00%,主力资金累计净流出16万元;近20日主力资金累计净流出16万元,其中净流出天数为2日。该股主力净额占比0.02%,港股市场排名2519/2620。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113161621826eb574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231113161621826eb574&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinco-pharm.com","stockEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":-0.0385},{"period":"3month","weight":0.0163},{"period":"6month","weight":0.0288},{"period":"1year","weight":-0.3298},{"period":"ytd","weight":0.0417}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"兴科蓉医药控股有限公司主要在中华人民共和国(中国)制药行业提供营销、推广和渠道管理(MPCM)服务。该公司向在中国没有独立营销和推广能力的中小型海外制药厂商提供综合的MPCM服务。其主要产品是人血清蛋白注射液。该产品是由Octapharma制造的人血清蛋白,用于治疗血容量不足和低血容量性休克、异常高的颅内压、水肿和腹水,以及预防和治疗低白蛋白血症和新生儿高胆红素血症。此外,其产品还包括安可欣、麦道必、爱赛福、泰特和滔罗特等。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.017778},{"month":2,"riseRate":0.625,"avgChangeRate":0.168249},{"month":3,"riseRate":0.375,"avgChangeRate":0.021738},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.080688},{"month":5,"riseRate":0.25,"avgChangeRate":-0.067404},{"month":6,"riseRate":0.125,"avgChangeRate":-0.098573},{"month":7,"riseRate":0.5,"avgChangeRate":0.058236},{"month":8,"riseRate":0.125,"avgChangeRate":-0.213788},{"month":9,"riseRate":0.375,"avgChangeRate":-0.015464},{"month":10,"riseRate":0.75,"avgChangeRate":0.212816},{"month":11,"riseRate":0.5,"avgChangeRate":0.085849},{"month":12,"riseRate":0.75,"avgChangeRate":0.077269}],"exchange":"SEHK","name":"兴科蓉医药","nameEN":"SINCO PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"兴科蓉医药(06833)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供兴科蓉医药(06833)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"兴科蓉医药,06833,兴科蓉医药股票,兴科蓉医药股票老虎,兴科蓉医药股票老虎国际,兴科蓉医药行情,兴科蓉医药股票行情,兴科蓉医药股价,兴科蓉医药股市,兴科蓉医药股票价格,兴科蓉医药股票交易,兴科蓉医药股票购买,兴科蓉医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"兴科蓉医药(06833)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供兴科蓉医药(06833)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}